References
- Bozfakioğlu S, Alptekin N, Seçkin S, et al. Red cell lipid peroxidation and antioxidant system in chronic renal failure patients treated with recombinant human erythropoietin. Nephron 1992; 61: 228–229
- Chakraborty M, Ghosal J, Biswas T, et al. Effect of erythropoietin on membrane lipid peroxidation, super‐oxide dismutase, catalase and glutathione peroxidase of rat rbc. Biochem Med Metal Biol 1988; 40: 8–18
- Djordjevic V, Djordjevic V B, Pejovic M, et al. Antioxidant enzymes in erythrocytes of patients on maintenance hemodialysis treated with human recombinant erythropoietin. Bio News Sci 1993; 30: 3–33
- Erslev A J. Humoral regulation of red cell production. Blood 1953; 8: 349–387
- Eschbach J W, Adamson J W. Anemia of end‐stage renal disease. Kidney Int 1985; 28: 1–5
- Eschbach J W. The anemia of chronic renal failure. Pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989; 35: 134–148
- Eschbach J W, Adamson J W. Recombinant human erythropoietin: implications for nephrology. Am J Kidney Dis 1988; 11(3)203–209
- Halliwell B. Drug antioxidant effects. Drugs 1991; 42(4)569–4305
- Jacobs K, Shoemaker C, Rudersdorf R, et al. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985; 313: 806–810
- Jacobson L O, Goldwasser E, Fried W, et al. Role of the kidney in erythropoiesis. Nature 1957; 179: 633–634
- Kurado M, Asaka S, Tofuku Y, et al. Serum antioxidant activity in uremic patients. Nephron 1985; 41: 293–298
- Luciak M, Kedziora J, Blaszczyk J, et al. Does recombinant human erythropoietin therapy modify intradialytic erythrocyte oxidative metabolism in chronic uremic patients?. Bio News Sci 1993; 28(6)31
- McCord J. Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 1993; 26: 351–357
- Maher E R, Wickens D G, Griffin F A, et al. Increased free radical activity during haemodialysis. Nephrol Dial Transplant 1987; 2: 169–171
- Naetz J ‐P, Heuse A F. Measurement of erythropoietic stimulating factor in anemic patients with or without renal disease. J Lab Clin Med 1962; 60: 365–374
- Paglia D E, Valentine W N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 233: 986–990
- Richard M, Arnaud J, Jurkovitz C, et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991; 57: 10–15
- Rudko I, Balashova T, Ermolenko V. The role of lipid peroxidation and Na+‐H+ exchange in the membrano protective action of erythropoietin. Bio News Sci 1993; 28: 5–41
- Schmidtmann S, Baehr R, Precht K. Free radicals induce increased lysis of red blood cells after haemodialysis. Nephrol Dial Transplant 1990; 5: 600–603
- Southorn P. Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin Proc 1988; 63: 381–389
- Tun S, Nemeth I, Varga I. The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure. Pediatr Nephrol 1992; 6(6)536–541
- Yagi K. Oxygen radicals in biological systems. Methods in enzymology, L Packer. Academic Press, New York 1984; vol 105: 328–331
- Yawata Y, Jacob H. Abnormal red cell metabolism in patients with chronic uremia: nature of the defect and its percistence despite adequate hemodialysis. Blood 1975; 45: 231–239
- Zachee P, Van Hove L, Hauglustaine D, et al. Effect of recombinant human erythropoietin on reticulocyte age in hemodialysis patients. Nephron 1992; 62: 366–367
- Zachee P, Ferrant A, Daelemans R, et al. Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment. Nephron 1993; 65: 288–293